A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of multiple therapeutic drugs and drugs of abuse in a clinical specimen.
| Company | Devices | Share |
|---|---|---|
| Utak Laboratories, Inc. | 175 | 64% |
| Bio-Rad Laboratories, Inc. | 57 | 21% |
| Roche Diagnostics Gmbh | 8 | 3% |
| Microgenics Corporation | 7 | 3% |
| Lgc Clinical Diagnostics, Inc. | 7 | 3% |
| Aalto Scientific | 7 | 3% |
| Randox Laboratories Limited | 4 | 1% |
| Beckman Coulter, Inc. | 3 | 1% |
| Carolina Liquid Chemistries Corporation | 2 | 1% |
| Germaine Laboratories, Inc | 2 | 1% |
| Siemens Healthcare Diagnostics Products Ltd | 2 | 1% |
Company = labeler of record on GUDID. 11 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| LAS | Drug Specific Control Materials | 173 |
| DIF | DRUG MIXTURE CONTROL MATERIALS | 50 |
| DIF | Drug Mixture Control Materials | 16 |
| DIF | Drug mixture control materials | 11 |
| DKB | Calibrators, Drug Mixture | 6 |
| JJY | Multi-analyte controls, all kinds (assayed) | 4 |
Use these as the dimensions to specify in a tender line.
274 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Multiple therapeutic drugs/drugs of abuse IVD, control", from 11 companies. The largest labeler is Utak Laboratories, Inc. with 64% of records.
LAS (Drug Specific Control Materials), DIF (DRUG MIXTURE CONTROL MATERIALS), DIF (Drug Mixture Control Materials), DIF (Drug mixture control materials)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add multiple therapeutic drugs/drugs of abuse ivd, control to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.